Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shixin Xu has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Yuying Guo
Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China; Tianjin Key Laboratory of Translational Research of TCM Prescription and Syndrome, Tianjin, China
12 shared publicationsYunsha Zhang
School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
10 shared publications- Junping Zhang
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China
8 shared publications - Linna Zhao
Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China; Tianjin Key Laboratory of Translational Research of TCM Prescription and Syndrome, Tianjin, China
7 shared publications Aiqin Zhong
North Hospital Emergency Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China
6 shared publicationsWenzhe Xu
Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China; Tianjin University of Traditional Chinese Medicine, Tianjin, China
6 shared publications
Latest Publications
- 25 October 2026
- Published by Elsevier in Clinical Immunology
- Vol. 288, 110787
Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets
- 25 October 2026
- Published by Elsevier in Clinical Immunology
- Vol. 288, 110787
Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets
- 12 April 2026
- Published by Elsevier in Fitoterapia
- Vol. 191, 107245
Shunaoxin dropping pills alleviate cerebral ischemia-reperfusion injury in MCAO rats associated with ferroptosis inhibition and AKT/Nrf2/HO-1 pathway activation
- 12 April 2026
- Published by Elsevier in Fitoterapia
- Vol. 191, 107245
Shunaoxin dropping pills alleviate cerebral ischemia-reperfusion injury in MCAO rats associated with ferroptosis inhibition and AKT/Nrf2/HO-1 pathway activation
- 26 March 2026
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 82  (1)
Gut microbiota-derived extracellular vesicles: novel perspectives from host-microbe interactions to therapeutic applications
- 26 March 2026
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 82  (1)
Gut microbiota-derived extracellular vesicles: novel perspectives from host-microbe interactions to therapeutic applications
- 20 November 2025
- Published by Elsevier in Experimental Neurology
- Vol. 397, 115563
BMSC-EVs improve post-stroke cognition by promoting regionally distinct synaptic repair via Sema3G-Nrp2/PlexinA4 Signaling
- 20 November 2025
- Published by Elsevier in Experimental Neurology
- Vol. 397, 115563
BMSC-EVs improve post-stroke cognition by promoting regionally distinct synaptic repair via Sema3G-Nrp2/PlexinA4 Signaling
- 4 September 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355  (Pt A) , 120520
Buyang Huanwu decoction promotes post-stroke white matter repair via TREM2-Dependent microglial phagocytosis and IGF1 secretion
- 4 September 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355  (Pt A) , 120520
Buyang Huanwu decoction promotes post-stroke white matter repair via TREM2-Dependent microglial phagocytosis and IGF1 secretion
- 14 September 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62  (3) , 3322-3342
The Aging Immune System: A Critical Attack on Ischemic Stroke
Ischemic stroke caused by cerebrovascular embolism is an age-related disease with high rates of disability and mortality. Although the mechanisms of immune and inflammatory development after stroke have been of great interest, most studies have neglected the critical and unavoidable factor of age. As the global aging trend intensifies, the number of stroke patients is constantly increasing, emphasizing the urgency of finding effective measures to address the needs of elderly stroke patients. The concept of “immunosenescence” appears to explain the worse stroke outcomes in older individuals. Immune remodeling due to aging involves dynamic changes at all levels of the immune system, and the overall consequences of central (brain-resident) and peripheral (non-brain-resident) immune cells in stroke vary according to the age of the individual. Lastly, the review outlines recent strategies aimed at immunosenescence to improve stroke prognosis.
- 14 September 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62  (3) , 3322-3342
The Aging Immune System: A Critical Attack on Ischemic Stroke
Ischemic stroke caused by cerebrovascular embolism is an age-related disease with high rates of disability and mortality. Although the mechanisms of immune and inflammatory development after stroke have been of great interest, most studies have neglected the critical and unavoidable factor of age. As the global aging trend intensifies, the number of stroke patients is constantly increasing, emphasizing the urgency of finding effective measures to address the needs of elderly stroke patients. The concept of “immunosenescence” appears to explain the worse stroke outcomes in older individuals. Immune remodeling due to aging involves dynamic changes at all levels of the immune system, and the overall consequences of central (brain-resident) and peripheral (non-brain-resident) immune cells in stroke vary according to the age of the individual. Lastly, the review outlines recent strategies aimed at immunosenescence to improve stroke prognosis.
- 19 June 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 333, 118474
Buyang huanwu decoction alleviates stroke-induced immunosuppression in MCAO mice by reducing splenic T cell apoptosis triggered by AIM2 inflammasome
- 19 June 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 333, 118474
Buyang huanwu decoction alleviates stroke-induced immunosuppression in MCAO mice by reducing splenic T cell apoptosis triggered by AIM2 inflammasome
- 22 December 2023
- Published by Elsevier in Clinical Immunology
- Vol. 259, 109881
AIM2 inflammasome: A potential therapeutic target in ischemic stroke
- 22 December 2023
- Published by Elsevier in Clinical Immunology
- Vol. 259, 109881
AIM2 inflammasome: A potential therapeutic target in ischemic stroke
- 27 November 2023
- Published by Elsevier in Experimental Neurology
- Vol. 372, 114619
Bone marrow mesenchymal stem cells therapy regulates sphingolipid and glycerophospholipid metabolism to promote neurological recovery in stroke rats: A metabolomics analysis
- 27 November 2023
- Published by Elsevier in Experimental Neurology
- Vol. 372, 114619
Bone marrow mesenchymal stem cells therapy regulates sphingolipid and glycerophospholipid metabolism to promote neurological recovery in stroke rats: A metabolomics analysis
- 3 October 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 479  (9) , 2217-2243
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances
There are complex interactions between the gut and the brain. With increasing research on the relationship between gut microbiota and brain function, accumulated clinical and preclinical evidence suggests that gut microbiota is intimately involved in the pathogenesis of neurodegenerative diseases (NDs). Increasingly studies are beginning to focus on the association between gut microbiota and central nervous system (CNS) degenerative pathologies to find potential therapies for these refractory diseases. In this review, we summarize the changes in the gut microbiota in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis and contribute to our understanding of the function of the gut microbiota in NDs and its possible involvement in the pathogenesis. We subsequently discuss therapeutic approaches targeting gut microbial abnormalities in these diseases, including antibiotics, diet, probiotics, and fecal microbiota transplantation (FMT). Furthermore, we summarize some completed and ongoing clinical trials of interventions with gut microbes for NDs, which may provide new ideas for studying NDs.
- 3 October 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 479  (9) , 2217-2243
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances
There are complex interactions between the gut and the brain. With increasing research on the relationship between gut microbiota and brain function, accumulated clinical and preclinical evidence suggests that gut microbiota is intimately involved in the pathogenesis of neurodegenerative diseases (NDs). Increasingly studies are beginning to focus on the association between gut microbiota and central nervous system (CNS) degenerative pathologies to find potential therapies for these refractory diseases. In this review, we summarize the changes in the gut microbiota in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis and contribute to our understanding of the function of the gut microbiota in NDs and its possible involvement in the pathogenesis. We subsequently discuss therapeutic approaches targeting gut microbial abnormalities in these diseases, including antibiotics, diet, probiotics, and fecal microbiota transplantation (FMT). Furthermore, we summarize some completed and ongoing clinical trials of interventions with gut microbes for NDs, which may provide new ideas for studying NDs.